Big variations in price from provider to provider could be adding to your bills—even if you're insured.» Read More
The WHO’s recent warning about germs resistant to antibiotics has raised questions about what pharma companies are doing to fight this.
A report released Wednesday said one-third of people who signed up for health insurance through new federal exchanges hadn't paid their first month's premium.
As rivals assessed what Pfizer's play for AstraZeneca could mean for the industry, one aspect touched nearly everyone: What it could mean for a U.S. tax loophole.
Danish insulin manufacturer has posted 15 percent growth in first-quarter operating profit but cut its sales outlook for 2014.
Four companies that charged New Yorkers as much as 55 percent interest for medical loans will pay 317 borrowers about $230,000 to settle usury claims.
Two proposals in Congress are taking aim at deadly superbugs. But it's not exactly clear to some experts just what the right medicine should be.
A majority of the nation's states either declined or failed to improve in nearly two dozen health indicators from 2007 to 2012, a new report said.
Ian Read, CEO of Pfizer, flew into London for a round of meetings with politicians and investors ahead of an expected fresh bid for AstraZeneca.
WellPoint reported profit that beat analysts' expectations and said individual exchanges were operating at a profit.
GlaxoSmithKline's sales fell 10%, highlighting the pressures behind last week's decision to trade more than $20 billion of assets with Novartis.
A new NBC News/Wall Street Journal poll shows that 44 percent of Americans now approve of Obama's job performance as Obamacare enrollment grows.
At the heart of Pfizer's pursuit of AstraZeneca is a shortage of products in its research pipeline, aggravated by a series of disappointing drug launches.
Merck reported better-than-expected quarterly earnings, helped by cost cuts and asset sales, but revenue came in slightly below expectations.
Today, wearable devices can monitor our health, track our diets -- and potentially save our lives. How?
Would you mind paying a fee at restaurants, supermarkets, and gas stations to help merchants offer health insurance to employees? One survey says yes.
Women who get chemotherapy for breast cancer may end up unemployed for a very long time, researchers reported on Monday.
WellPoint bet big Obamacare, and investors expect the nation's largest provider of Blue Cross plans to report large membership gains.
Shares in UK pharma group soar 15 percent on news that potential $100 billion-plus merger seems to have moved a step closer.
Bayer CEO Marijn Dekkers told CNBC he did not feel a need to make acquisitions on Monday.
One physical therapist billed Medicare for 183,000 treatments in 2012. That's 500 a day, 21 an hour. The NYT reports.
Get the best of CNBC in your inbox